Skip to main content

Stem cell marker CD133 (PROMININ-1) is epigenetically regulated in ovarian cancer

Publication ,  Conference
Baba, T; Convey, P; Matsumura, N; Whitaker, RS; Perry, T; Huang, Z; Mori, S; Kondoh, E; Bentley, RC; Fujii, S; Berchuck, A; Murphy, SK; Marks, JR
Published in: CANCER BIOMARKERS
2008

Duke Scholars

Published In

CANCER BIOMARKERS

ISSN

1574-0153

Publication Date

2008

Volume

4

Issue

3

Start / End Page

175 / 176

Related Subject Headings

  • Oncology & Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Baba, T., Convey, P., Matsumura, N., Whitaker, R. S., Perry, T., Huang, Z., … Marks, J. R. (2008). Stem cell marker CD133 (PROMININ-1) is epigenetically regulated in ovarian cancer. In CANCER BIOMARKERS (Vol. 4, pp. 175–176).
Baba, Tsukasa, Patricia Convey, Noriomi Matsumura, Regina S. Whitaker, Tiffany Perry, Zhiqing Huang, Seiichi Mori, et al. “Stem cell marker CD133 (PROMININ-1) is epigenetically regulated in ovarian cancer.” In CANCER BIOMARKERS, 4:175–76, 2008.
Baba T, Convey P, Matsumura N, Whitaker RS, Perry T, Huang Z, et al. Stem cell marker CD133 (PROMININ-1) is epigenetically regulated in ovarian cancer. In: CANCER BIOMARKERS. 2008. p. 175–6.
Baba, Tsukasa, et al. “Stem cell marker CD133 (PROMININ-1) is epigenetically regulated in ovarian cancer.” CANCER BIOMARKERS, vol. 4, no. 3, 2008, pp. 175–76.
Baba T, Convey P, Matsumura N, Whitaker RS, Perry T, Huang Z, Mori S, Kondoh E, Bentley RC, Fujii S, Berchuck A, Murphy SK, Marks JR. Stem cell marker CD133 (PROMININ-1) is epigenetically regulated in ovarian cancer. CANCER BIOMARKERS. 2008. p. 175–176.

Published In

CANCER BIOMARKERS

ISSN

1574-0153

Publication Date

2008

Volume

4

Issue

3

Start / End Page

175 / 176

Related Subject Headings

  • Oncology & Carcinogenesis